// App-Quantinova.ai

594.0 : Tumor budding is a strong predictor of disease-free survival in stage II colorectal cancer: Validation study based on the International Tumor Budding Consensus Conference (ITBCC) recommendations.

Researchers

Presenter

  • Heather Dawson

Principal Investigators

  • Naziheh Assarzadegan

  • Robert Riddell

  • Richard Kirsch

  • Annika Blank

  • Inti Zlobec

  • Alessandro Lugli

Medical Centers

  • University of Bern, Bern, Switzerland

  • Pathology, immunology and Laboratory Medicine, University of Florida, Gainesville, FL, United States

  • Department of Pathology and Laboratory Medicine, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

Locations

  • Switzerland

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved